Alteogen Inc. Logo

Alteogen Inc.

Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.

196170 | KO

Overview

Corporate Details

ISIN(s):
KR7196170005
LEI:
Country:
South Korea
Address:
대전광역시 유성구 유성대로1628번길 62 (전민동 461-38번지), 대전광역시

Description

Alteogen Inc. is a biopharmaceutical company focused on the development and commercialization of next-generation biologics. The company's core activities are centered on its proprietary platform technologies. These include Hybrozyme™, a novel recombinant human hyaluronidase (ALT-B4) technology that enables the conversion of intravenous (IV) therapies to subcutaneous (SC) formulations, enhancing patient convenience. Additionally, Alteogen develops long-acting biobetters utilizing its NexP™ fusion technology, proprietary antibody-drug conjugates (ADCs), and antibody biosimilars. The company's pipeline is aimed at creating therapies with enhanced efficacy and delivery methods for serious diseases.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-04-03 00:00
투자판단관련주요경영사항(ALT-B4 관련 마일스톤 기술료 수령)
Korean 9.2 KB
2023-03-28 00:00
정기주주총회결과
Korean 21.3 KB
2023-03-28 00:00
주식매수선택권부여에관한신고
Korean 13.9 KB
2023-03-24 00:00
[기재정정]사업보고서 (2022.12)
Korean 2.0 MB
2023-03-23 00:00
소송등의판결ㆍ결정
Korean 6.9 KB
2023-03-20 00:00
감사보고서제출
Korean 24.7 KB
2023-03-20 00:00
사업보고서 (2022.12)
Korean 2.0 MB
2023-03-14 00:00
의결권대리행사권유참고서류
Korean 53.9 KB
2023-03-14 00:00
[기재정정]의결권대리행사권유참고서류
Korean 56.6 KB
2023-03-13 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 12.4 KB
2023-03-13 00:00
주주총회소집결의
Korean 9.4 KB
2023-03-13 00:00
주주총회소집공고
Korean 229.9 KB
2023-03-13 00:00
의결권대리행사권유참고서류
Korean 175.0 KB
2023-02-28 00:00
소송등의제기ㆍ신청(경영권분쟁소송)
Korean 6.2 KB
2023-02-08 00:00
[기재정정]투자판단관련주요경영사항(ALT-BB4(Tergase) 테르가제주 품목허가 신청)
Korean 15.3 KB

Automate Your Workflow. Get a real-time feed of all Alteogen Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Alteogen Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Alteogen Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.